After CEO move, GSK picks ex-Novartis exec to head consumer unit
- Apple (AAPL) Tops Q4 EPS by 2c; Issues Solid Outlook
- Wall Street slips on earnings; Apple falls late after results
- Chipotle Mexican Grill (CMG) Posts Q3 EPS of $0.27; Comps Miss Views; Additional Stock Buyback Approved
- Pandora (P) Misses Q3 EPS by 1c, Q4 Revenue Guidance Falls Short
- After-Hours Movers 10/25: (OGXI) (AKAM) (VRTX) Higher; (EW) (NUVA) (CMG) (AAPL) Lower (more...)
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville/File Photo
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
LONDON (Reuters) - GlaxoSmithKline (NYSE: GSK) has promoted a former Novartis (NASDAQ: NOVN) executive to lead its consumer healthcare business, following the appointment last week of the unit's previous head, Emma Walmsley, as CEO designate of the drugmaker.
The British group said on Thursday that Brian McNamara, 50, who currently heads up Europe and the Americas at GSK Consumer Healthcare, would take on his new role immediately and join GSK's corporate executive team.
McNamara worked for 11 years at Novartis, where he was also in charge of consumer health, and joined GSK following the creation of a joint venture between the two companies in 2015. Prior to that he spent 16 years at Procter & Gamble (NYSE: PG).
The swift management transition will ensure the consumer business remains focused on improving financial performance and will allow Walmsley to focus on her new role as incoming CEO, a spokesman said.
She will officially take the helm at the end of March on the retirement of current CEO Andrew Witty, becoming the first woman to lead a top global drugmaker.
Separately, GSK said it had disposed of the final portion of its stake in Aspen Pharmacare
(Reporting by Ben Hirschler; Editing by Adrian Croft)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amnesty says U.S. coalition underestimated impact on civilians in Syria
- Asia stocks slide after Wall Street losses, oil drops on glut concerns
- White House weighing whether greenhouse gas deal needs Senate approval
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!